4.70
+0.01(+0.21%)
Currency In USD
| Previous Close | 4.69 |
| Open | 4.65 |
| Day High | 4.81 |
| Day Low | 4.63 |
| 52-Week High | 10.15 |
| 52-Week Low | 4.22 |
| Volume | 29,759 |
| Average Volume | 56,192 |
| Market Cap | 178.66M |
| PE | -2.94 |
| EPS | -1.6 |
| Moving Average 50 Days | 5.54 |
| Moving Average 200 Days | 5.9 |
| Change | 0.01 |
If you invested $1000 in Orchestra BioMed Holdings, Inc. (OBIO) since IPO date, it would be worth $412.28 as of December 26, 2024 at a share price of $4.7. Whereas If you bought $1000 worth of Orchestra BioMed Holdings, Inc. (OBIO) shares 3 years ago, it would be worth $477.16 as of December 26, 2024 at a share price of $4.7.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Orchestra BioMed Announces AVIM Therapy Program Presentations at ICI Meeting
GlobeNewswire Inc.
Dec 09, 2024 12:00 PM GMT
NEW HOPE, Pa., Dec. 09, 2024 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing part
Orchestra BioMed to Participate in the Piper Sandler 36th Annual Healthcare Conference
GlobeNewswire Inc.
Nov 26, 2024 9:05 PM GMT
NEW HOPE, Pa., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, t
Orchestra BioMed to Participate in Jefferies London Healthcare Conference
GlobeNewswire Inc.
Nov 07, 2024 1:00 PM GMT
NEW HOPE, Pa., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, t